Ethyl 1-benzyl-5,5-difluoro-4-oxopiperidine-3-carboxylate
95%
- Product Code: 82224
CAS:
1067915-34-7
| Molecular Weight: | 297.3 g./mol | Molecular Formula: | C₁₅H₁₇F₂NO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD16036533 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry, sealed |
Product Description:
This compound is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological and metabolic disorders. Its structural features, including the difluoro and oxopiperidine moieties, make it a valuable building block for designing compounds with enhanced potency and selectivity. Researchers often employ it in the preparation of potential drug candidates for conditions such as Alzheimer’s disease, Parkinson’s disease, and diabetes. Additionally, its ester functional group allows for further chemical modifications, enabling the creation of diverse derivatives for screening and optimization in drug discovery programs.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | $152.55 |
+
-
|
| 1.000 | 10-20 days | $304.74 |
+
-
|
| 5.000 | 10-20 days | $913.86 |
+
-
|
Ethyl 1-benzyl-5,5-difluoro-4-oxopiperidine-3-carboxylate
This compound is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological and metabolic disorders. Its structural features, including the difluoro and oxopiperidine moieties, make it a valuable building block for designing compounds with enhanced potency and selectivity. Researchers often employ it in the preparation of potential drug candidates for conditions such as Alzheimer’s disease, Parkinson’s disease, and diabetes. Additionally, its ester functional group allows for further chemical modifications, enabling the creation of diverse derivatives for screening and optimization in drug discovery programs.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :